According to the ministry’s Drug Administration of Việt Nam (DAV), innovative drugs in Việt Nam account for only about 3 per cent of the total but represent up to 22 per cent of the value and are primarily imported. Only a few medicines have been researched and produced domestically, or have had initial technology transfer for production.